No insider purchase over the last 90 days. The latest, by KRAEMER HARRY M JANSEN JR, was filed 04 Nov 2025.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analysts rate Option Care Health, Inc. Hold (neutral), based on 8 analysts. Average price target: US$30.03.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 445 declarations
Option Care Health, Inc. has seen very large shareholder sales: Walgreens Boots Alliance, Inc. for EUR 443,305,120 on March 1, 2023 and EUR 357,017,019 on August 16, 2022, then Madison Dearborn Partners LLC, filed as Director, for EUR 354,160,947 on August 5, 2021. The 34 sales have a median of EUR 5,355,882, far above that of the 28 purchases, EUR 65,222, for EUR 14,856,632 in total, or 45% of open-market trades.
The largest purchase is Coliseum Capital Management, LLC's (Director): EUR 7,415,100 on June 22, 2016. Harry M. Jansen Kraemer Jr. bought EUR 1,734,273 on August 11, 2023 and EUR 1,020,653 on February 26, 2024. From August 20 to September 9, 2025, 5 filers bought for EUR 1,439,234. Across the full history, 22 purchase filings are classed as clustered. For 28 purchases, the stored 90-day results give a median of 8% with 71% positive (recorded past, not a forecast).
This US healthcare company, valued at USD 4.7 billion, has 328 filings from 42 filers, 188 of them grants. R. Carter Pate, Director, has 27, with 5 purchases and 6 sales. The year 2018 gathers 8, 2024 49. The last twelve months: 33 filings, 1 purchase, 2 sales. Insiders hold 1.3% of the capital.
| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 5.65 bn USD | 207.6 m USD | 1.27 USD | 10-K |
| Dec 2024 | 5.00 bn USD | 211.8 m USD | 1.23 USD | 10-K |
| Dec 2023 | 4.30 bn USD | 267.1 m USD | 1.48 USD | 10-K |
| Dec 2022 | 3.94 bn USD | 150.6 m USD | 0.83 USD | 10-K |
| Dec 2021 | 3.44 bn USD | 139.9 m USD | 0.77 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.